Skip to main content
Premium Trial:

Request an Annual Quote

NEWSBRIEF: Strong Life-Sciences Growth Buoys Bruker Daltonics Bottom Line

NEW YORK, May 6 - Bruker Daltonics today reported that strong first-quarter growth in its life-sciences business helped boost total revenue despite static or declining performance from other units.


Total revenue in the period ended March 31 grew to $25.7 million from $21.9 million one year ago. Of the company's total product revenues, life science systems accounted for 76 percent, up from 70 percent a year ago, Bruker said. Its substance-detection and aftermarket revenues represent 8 percent and 16 percent of product revenues this year, respectively, compared with 8 percent and 22 percent year over year.


R&D spending in the first quarter 2002 remained relatively flat at $4.5 million compared with $4.6 million reported during the same period one year ago. Total first-quarter costs and operating expenses, though, grew to $24.4 million from $21.2 million year over year.


Bruker also reported a dip in first-quarter net income to $941,000, or $.02 per share, compared with $945,000, or $.02 per share, in the first quarter 2001.


The company said it had $66.8 million in cash and short-term investments as of March 31, a slight drop from the $70.1 million it had as of Dec. 31, 2001.


For more information, click here.

The Scan

Guidelines for Ancient DNA Work

More than two dozen researchers have developed new ethical guidelines for conducting ancient DNA research, which they present in Nature.

And Cleared

A UK regulator has cleared former UK Prime Minister David Cameron in concerns he should have registered as a consultant-lobbyist for his work with Illumina, according to the Financial Times.

Suit Over Allegations

The Boston Globe reports that David Sabatini, who was placed on leave from MIT after allegations of sexual harassment, is suing his accuser, the Whitehead Institute, and the institute's director.

Nature Papers on Esophageal Cancer, Origin of Modern Horses, Exome Sequencing of UK Biobank Participants

In Nature this week: genetic and environmental influences of esophageal cancer, domestic horse origin traced to Western Eurasian steppes, and more.